Chinese Journal of Hepatology 2006 Issue 11 Recent advances in research of molecular mechanism in alcoholic fatty liver disease

Recent advances in research of molecular mechanism in alcoholic fatty liver disease
LI Yu

..............page:878-880

Progress in human hepatic progenitor cell research
ZHANG Wei;CHEN Xiao-ping

..............page:875-877

An introduction of a treatment algorithm for the management of chronic hepatitis B virus infection in the USA
ZHUANG Hui

..............page:871-874

Pegylated interferon alpha 2a in treating chronic hepatitis B patients
TIAN Yu-ling;ZHAO Wei;SHEN Ling;LIU Wei;CHANG Jia-bao;FANG Zhi-xun;YIN Wei-wei;WANG Lei;SUN Xi-bin;YANG Yi-jun

..............page:806-810

A double-blind, randomized, lamivudine-controlled clinical trial of DAIDINGTM (adefovir dipivoxil) for lamivudine-resistant patients with chronic hepatitis B
WANG Yu-ming;CHEN Yao-kai;ZHANG Da-zhi;LEI Bing-jun;LU Zhi-meng;YIN You-kuan;YU Yun-song

..............page:803-805

Strategies for treatment of chronic hepatitis B virus infection
REN Hong

..............page:801-802

Guidelines for the diagnosis and treatment of liver fibrosis in integrative medicine practice
Liver Disease Committee, Chinese Association of Integrative Medicine

..............page:866-870

The effects of refecoxib on inhibiting the growth and inducing apoptosis of hepatocellular carcinoma cell lines HepG2 and human normal liver cell line QSG7701
SHEN Wei-dong;LIU Peng-fei

..............page:863-865

Correlation between plasma soluble thrombomodulin level to the degree of liver inflammation in patients with chronic viral hepatitis
CHEN Cui-rong;CHEN Ya-gang

..............page:861-862

The distribution and significance of insulin-like growth factor binding protein in patients with liver fibrosis
TIAN Xiao-xia;QIN Gui-xiu;YUN Ke-ming;LIU Li-xin;HAN De-wu

..............page:858-860

Screening of target autoantigen in hepatocytes from hepatocyte cDNA library by phage display technique
LI Yun-ru;ZHANG Li-ying;CHENG Jun;WANG Pei-zhi;XIE Wen;WEI Lai

..............page:857-858

Therapeutic effects of Trigonella foenum-greacum saponin on rats with alcoholic fatty livers
zhang ( zuo ) zhi ;zhang yu;li lin-lin; zhang zuo ; li lin lin ; yang wei xing ; ran xin jian ; yang yong xin ; mao xin min

..............page:854-856

Effect of NAC on LPS-induced toll-like receptor 2 and 4 expressions in murine macrophages
JIN Xin;WU He-shui;TIAN Yuan;ZHANG Jin-hui;WANG Chun-you

..............page:852-854

The expression of CYP2E1 and its effect on the proliferation of C3A hepatocyte cell line
LIU Tian-hui;XU You-qing;YOU Hong;XU Yong;CONG Min;WANG Ping;JIA Ji-dong;WANG Bao-en

..............page:850-851

Expression of melittin tagged with green fluorescent protein and its use in hepatocellular carcinoma treatment
CHEN Jiang;WANG Wei-yu;LU Zhi-xian;CHENG Hua-li;CHEN Rong-fang;PAN Yu-hong;WU Xiao-long;ZHU Jian-zhong;CAO Li-min

..............page:847-849

Expression of angiotensinogen during development and spontaneous reversal of hepatic fibrosis
YANG Liu;LIU Hai-lin;HUO Li;WANG Lei

..............page:845-846

The effects of transforming growth factor beta1/Smads signaling pathway changes on the pathogenesis of liver fibrosis
KONG Li;ZHANG Yu-guo;WANG Rong-qi;YAO Shu-kun

..............page:842-844

Exploration of differential expressed genes involved in the development and progression of hepatocellular carcinoma using oligomicroarray
LIU Xiu-feng;SHI Rui-hua;GAO Heng-jun;ZHU Hong;QIN Shu-kui;WANG Xue-hao

..............page:824-827

Fasudil inhibites HSC adhesion, migration and proliferation via Rho/ROCK pathway
WANG Yu-zhen;JIANG Hui-qing;HU Cai-xia;CHEN Xin

..............page:821-823

Expression of endotoxin receptors on hepatic stellate cells during their activation
HUA Jing;QIU De-kai;LI Ji-qiang;LI En-ling

..............page:817-820

Foscarnet sodium for treatment in patients with severe chronic hepatitis B
YU Yan-yan;ZHANG Da-zhi;MIAO Xiao-hui;ZHU Chuan-lin;ZHOU Xia-qiu;YU Hao;SI Chong-wen

..............page:814-816

Study on the pharmacokinetic profile of telbivudine
JIANG Ji;HU Pei;WANG Hong-yun;SHEN Kai;Nathaniel A. Brown;ZHOU Xiao-jian

..............page:811-813

The dynamic changes of hepatitis C virus quasispecies during natural infections
FAN Wen-mei;ZHU Wan-fu;WEI Lai;YIN Li-min

..............page:839-841

Antiviral treatment for hepatitis B virus related liver cirrhosis
XIE Qing;GUI Hong-lian

..............page:837-838

Focusing on the markers for monitoring and antiviral therapy in chronic hepatitis B virus infection
WEI Lai

..............page:836-837

How long should patients with chronic hepatitis B virus infection be treated?
JIA Ji-dong

..............page:835

An analysis of 276 cases of drug-induced liver damage
LU Wei-ting;LI Jun;OU Ning;CHEN Nian;LIU Yuan;GUO Xue-jiang;WANG Rui-yun;LU Xiang;HUANG Jun

..............page:832-834

Relationship between leptin gene of adipose tissues and nonalcoholic fatty liver disease
YANG Hui;LI Yu-yuan;NIE Yu-qiang;HONG Yong;JIANG Qing-lan;SHA Wei-hong

..............page:828-831